Cargando…

Influenza neuraminidase

Please cite this paper as: Air. (2012) Influenza neuraminidase. Influenza and Other Respiratory Viruses 6(4), 245–256. Influenza neuraminidase is the target of two licensed antivirals that have been very successful, with several more in development. However, neuraminidase has been largely ignored as...

Descripción completa

Detalles Bibliográficos
Autor principal: Air, Gillian M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290697/
https://www.ncbi.nlm.nih.gov/pubmed/22085243
http://dx.doi.org/10.1111/j.1750-2659.2011.00304.x
_version_ 1782225038513012736
author Air, Gillian M.
author_facet Air, Gillian M.
author_sort Air, Gillian M.
collection PubMed
description Please cite this paper as: Air. (2012) Influenza neuraminidase. Influenza and Other Respiratory Viruses 6(4), 245–256. Influenza neuraminidase is the target of two licensed antivirals that have been very successful, with several more in development. However, neuraminidase has been largely ignored as a vaccine target despite evidence that inclusion of neuraminidase in the subunit vaccine gives increased protection. This article describes current knowledge on the structure, enzyme activity, and antigenic significance of neuraminidase.
format Online
Article
Text
id pubmed-3290697
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-32906972013-07-01 Influenza neuraminidase Air, Gillian M. Influenza Other Respir Viruses Review Articles Please cite this paper as: Air. (2012) Influenza neuraminidase. Influenza and Other Respiratory Viruses 6(4), 245–256. Influenza neuraminidase is the target of two licensed antivirals that have been very successful, with several more in development. However, neuraminidase has been largely ignored as a vaccine target despite evidence that inclusion of neuraminidase in the subunit vaccine gives increased protection. This article describes current knowledge on the structure, enzyme activity, and antigenic significance of neuraminidase. Blackwell Publishing Ltd 2011-11-16 2012-07 /pmc/articles/PMC3290697/ /pubmed/22085243 http://dx.doi.org/10.1111/j.1750-2659.2011.00304.x Text en © 2011 Blackwell Publishing Ltd
spellingShingle Review Articles
Air, Gillian M.
Influenza neuraminidase
title Influenza neuraminidase
title_full Influenza neuraminidase
title_fullStr Influenza neuraminidase
title_full_unstemmed Influenza neuraminidase
title_short Influenza neuraminidase
title_sort influenza neuraminidase
topic Review Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3290697/
https://www.ncbi.nlm.nih.gov/pubmed/22085243
http://dx.doi.org/10.1111/j.1750-2659.2011.00304.x
work_keys_str_mv AT airgillianm influenzaneuraminidase